← Leaderboards
Anusha Kalbasi
Stanford University
$2,561,500
Attributed
$2,561,500
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $598.1K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,561,500 · 2
By mechanism
R37$1,419,305 · 1
K08$1,142,195 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- William H Robinson$16,848,609
- Minnie M Sarwal$8,971,142
- Olivia M Martinez$20,491,021
- Edgar G. Engleman$35,389,843
- Prasanna Jagannathan$10,796,952
Others in their field
Other Emerging Leaders on “Immunotherapy”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,653,178
- Leonard Freedman · Leidos Biomedical Research, Inc.$66,640,671
- Leonard Freedmand · Leidos Biomedical Research, Inc.$54,755,085
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$28,983,611
Research focus
ImmunotherapyIn VitroCellsInfiltrationSignal TransductionAdoptive TransferPhenotypeMouse ModelT-LymphocyteTranscriptomicsTumorCytokineSuccessResearch PersonnelAntigensChemotherapyProgramsAntigen PresentationAreaAdoptedAntsCancer ImmunotherapyAntitumor ResponseAdult
Grant awards (10)
Synthetic IL9R signaling to rewire T cells for adoptive cell therapy of cancer$357,209
R37 · FY2025 · CA · contact PI
Targeting Radiation-Induced Myeloid Cells to Promote T cell Immunity in Undifferentiated Pleomorphic Sarcoma$228,439
K08 · FY2025 · CA · contact PI
Synthetic IL9R signaling to rewire T cells for adoptive cell therapy of cancer$339,350
R37 · FY2024 · CA · contact PI
Targeting Radiation-Induced Myeloid Cells to Promote T cell Immunity in Undifferentiated Pleomorphic Sarcoma$228,439
K08 · FY2024 · CA · contact PI
Synthetic IL9R signaling to rewire T cells for adoptive cell therapy of cancer$353,100
R37 · FY2023 · CA · contact PI
Synthetic IL9R signaling to rewire T cells for adoptive cell therapy of cancer$369,646
R37 · FY2022 · CA · contact PI
Targeting Radiation-Induced Myeloid Cells to Promote T cell Immunity in Undifferentiated Pleomorphic Sarcoma$141,413
K08 · FY2022 · CA · contact PI
Targeting Radiation-Induced Myeloid Cells to Promote T cell Immunity in Undifferentiated Pleomorphic Sarcoma$87,026
K08 · FY2022 · CA · contact PI
Targeting Radiation-Induced Myeloid Cells to Promote T cell Immunity in Undifferentiated Pleomorphic Sarcoma$228,439
K08 · FY2021 · CA · contact PI
Targeting Radiation-Induced Myeloid Cells to Promote T cell Immunity in Undifferentiated Pleomorphic Sarcoma$228,439
K08 · FY2020 · CA · contact PI